
ClearPoint Neuro CLPT
$ 11.18
-0.18%
Quarterly report 2026-Q1
added 05-13-2026
ClearPoint Neuro ROE Ratio 2011-2026 | CLPT
Annual ROE Ratio ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -91.15 | -74.5 | -104.33 | -44.55 | -29.54 | -285.32 | -120.78 | -407.91 | -122.97 | 1067.35 | 426.48 | 4509.85 | 103.69 | 102.45 | - | 61.64 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4509.85 | -407.91 | 332.7 |
Quarterly ROE Ratio ClearPoint Neuro
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -147.52 | -113.98 | -90.58 | -73.01 | -42.86 | -62.82 | -71.39 | -74.89 | -62.9 | -72.4 | -62.49 | -45.42 | -28.21 | -37.23 | -35.53 | -31.25 | -22.59 | -85.03 | -145.88 | -224.53 | -218.76 | -243.25 | -214.62 | -171.35 | -84.9 | -179.41 | -279.12 | -353.92 | -327.3 | -351.76 | -291.63 | -195.85 | -87.25 | 251.77 | 511.91 | 816.62 | 845.03 | 857.42 | 672.86 | 636.31 | 365.99 | 4001.22 | 5576.69 | 2800.48 | 2601.34 | 2648.08 | -967.36 | -2543.16 | 78.59 | 153.31 | 181.29 | 236.24 | 224.19 | 262.24 | 225.56 | 161.13 | 86.4 | 38.05 | 38.05 | 10.3 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5576.69 | -2543.16 | 270.68 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-0.95 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
-1153.69 | $ 8.24 | - | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
192.9 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
-46.5 | $ 4.41 | 3.8 % | $ 165 M | ||
|
BioSig Technologies
BSGM
|
-347.45 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-13.59 | $ 2.31 | - | $ 50.9 M | ||
|
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-138.88 | $ 0.45 | -4.21 % | $ 28 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-11.44 | $ 18.27 | -1.24 % | $ 429 M | ||
|
Delcath Systems
DCTH
|
2.43 | $ 11.34 | 0.94 % | $ 406 M | ||
|
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | ||
|
LivaNova PLC
LIVN
|
-20.21 | $ 73.11 | -0.82 % | $ 3.99 B | ||
|
LENSAR
LNSR
|
131.75 | $ 6.09 | 3.57 % | $ 72.8 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-47.65 | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
-90.15 | $ 1.01 | 1.5 % | $ 17.1 M | ||
|
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | ||
|
MiMedx Group
MDXG
|
18.94 | $ 3.68 | -3.03 % | $ 544 M | ||
|
Pulmonx Corporation
LUNG
|
-99.79 | $ 1.54 | 0.09 % | $ 62.7 M | ||
|
Electromed
ELMD
|
17.44 | $ 38.46 | 1.91 % | $ 325 M | ||
|
Myomo
MYO
|
-136.8 | $ 0.93 | 1.27 % | $ 38.9 M | ||
|
Butterfly Network
BFLY
|
-39.32 | $ 4.45 | 1.25 % | $ 1.1 B | ||
|
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
169.16 | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
-20.49 | $ 10.54 | -13.25 % | $ 417 M | ||
|
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | ||
|
Profound Medical Corp.
PROF
|
-64.08 | $ 6.92 | - | $ 209 M | ||
|
Globus Medical
GMED
|
11.76 | $ 84.46 | 0.54 % | $ 11.4 B | ||
|
Insulet Corporation
PODD
|
16.31 | $ 155.13 | -0.93 % | $ 10.9 B | ||
|
CONMED Corporation
CNMD
|
4.55 | $ 36.47 | -1.46 % | $ 1.13 B | ||
|
Inspire Medical Systems
INSP
|
18.62 | $ 43.9 | -0.54 % | $ 1.29 B | ||
|
Sintx Technologies
SINT
|
-353.84 | $ 2.14 | -3.32 % | $ 5.94 M | ||
|
Integer Holdings Corporation
ITGR
|
5.89 | $ 89.82 | -1.76 % | $ 3.12 B | ||
|
Invacare Corporation
IVC
|
-25.37 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
10.38 | $ 82.73 | -0.29 % | $ 48.4 B | ||
|
TransMedics Group
TMDX
|
40.22 | $ 67.26 | -1.09 % | $ 2.29 B |